TokenPost·
McKesson Is Closing a $2.25 Billion Precision Medicine Group Deal
The deal comes as McKesson’s fiscal 2027 adjusted earnings outlook stands at $45.60 to $46.40 per diluted share.
More news
- Crypto BriefingUS diesel inventories hit lowest level since May 2003, tightening supply
- TokenPostNasdaq 100 Futures Fall 1.3% as U.S. Stock Contracts Diverge
- TokenPostReap Partners With Canza Finance on AI-Agent Stablecoin Payments
- TokenPostSiTime Forecasts Fourth-Quarter Revenue of $331 Million to $341 Million
- TokenPostSouth Korea’s KOSPI Cuts Losses After More Than 8.5% Drop, Still Down 5%
- UnchainedZcash Activates NU7, Taking 60% of Transaction Fees Out of Circulation